跳至主要内容
临床试验/DRKS00032455
DRKS00032455招募中不适用

Immune-mediated polyneuropathy/chronic inflammatory demyelinating polyneuropathy (CIDP): diagnostic, prognostic, and treatment-response markers - IP/CIDP-Kohorte

Charité - Universitätsmedizin Berlin0 个研究点目标入组 320 人开始时间: 2024年2月21日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
320

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Patients with CIDP or CIDP variants (DADS, MADSAM, purely sensory/purely motor, focal courses) or other immune-mediated polyneuropathies [multifocal motor neuropathy, polyneuropathy of the rheumatic type or chronic inflammatory bowel diseases, chronic inflammatory axonal polyneuropathy (CIAP) , autoimmune (para)nodopathies Guillian Barré Syndrome, polyneuropathies in the context of monoclonal gammopathies of unclear significance, anti-MAG neuropathies]
  • Age- and sex-matched subjects with polyneuropathy of other origin (hereditary, diabetic/toxic origin)
  • control patients of the same age and gender with central demyelinating disease (multiple sclerosis)
  • Age- and sex-matched healthy subjects with no other underlying autoimmune-mediated disease or comorbidities
  • Ability to consent and written informed consent

排除标准

  • 未提供

研究者

相似试验

Immune-mediated polyneuropathy/chronic inflammatory... | 临床试验